Effect of Intradialytic Exercises in Chronic Kidney Disease Patients
Intradialytic Aerobic Versus Resistive Exercises on Immunity Response in Patients With Chronic Kidney Disease
1 other identifier
interventional
60
1 country
1
Brief Summary
the purpose of this study is to compare between intradialytic aerobic versus resistive exercises on immunity response in patients with chronic kidney disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2024
CompletedFirst Submitted
Initial submission to the registry
February 13, 2024
CompletedFirst Posted
Study publicly available on registry
March 5, 2024
CompletedMarch 5, 2024
March 1, 2024
1.5 years
February 13, 2024
March 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Concentration of immunoglobulin g
measured by mg/dl
baseline , 12 weeks for each patient
Total leukocyte count
measured by (cell/mcl)\*\*\*\*1000
baseline , 12 weeks for each patient
lymphocyte count
measured by (cell/mcl)\*\*\*\*1000
baseline , 12 weeks for each patient
neutrophil count
measured by (cell/mcl)\*\*\*\*1000
baseline , 12 weeks for each patient
Concentration of HbA1c
measured by percentage of blood sugar last 3 months
baseline , 12 weeks for each patient
Secondary Outcomes (6)
hemoglobin concentration
baseline , 12 weeks for each patient
thrombocytes count
baseline , 12 weeks for each patient
diastolic blood pressure
baseline , 12 weeks for each patient
Systolic blood pressure
baseline , 12 weeks for each patient
six minute walk test
baseline , 12 weeks for each patient
- +1 more secondary outcomes
Study Arms (3)
control group C
EXPERIMENTALreceive hemodialysis sessions
study group A aerobic exercise
EXPERIMENTALreceive hemodialysis sessions and intradialytic aerobic exercise
study group B resistive exercise
EXPERIMENTALreceive hemodialysis sessions and intradialytic resistive exercise
Interventions
Intradialytic aerobic cycling exercise program ,each patient will receive the treatment program three times per week for three months.
Intradialytic resistive exercise program , each patient will receive the treatment program three times per week for three months.
hemodialysis sessions ,each patient will receive the treatment program three times per week for three months.
Eligibility Criteria
You may qualify if:
- Sixty men chronic kidney disease (grade III RF). They received regular hemodialysis sessions at least one year ago, each one for four hours, three times per week.
- They had a history of type II Diabetes more than five years.
- Their age will be ranged from 50-60 years old.
- They are Fit for exercise by functional assessment using six minute walk test.
- Their Hemoglobin level more than 10 g\\dl.
- Their Body Mass Index (BMI) will be ranged from "18.5" to "24.9".
You may not qualify if:
- Severe cardiac disorders.
- Severe orthopedic problems (for example fractures).
- Hepatic encephalopathy.
- Preexisting neuromuscular diseases (e.g. myasthenia gravis). •Severe chest diseases.
- Spinal cord injuries involved the phrenic nerve.
- Uncontrolled diabetes or hypertension
- Patients receiving inefficient hemodialysis session.
- Patients with other cause for inflammation e.g. malignancy and autoimmune disease.
- Active bleeding as alveolar hemorrhage, hemoptysis.
- Physical limitation that would limit cycling.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Fayoum hospital
Al Fayyum, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- physiotherapist
Study Record Dates
First Submitted
February 13, 2024
First Posted
March 5, 2024
Study Start
April 30, 2022
Primary Completion
October 30, 2023
Study Completion
January 30, 2024
Last Updated
March 5, 2024
Record last verified: 2024-03